Adamis Pharma Stock Number Of Shares Shorted
| ADMPDelisted Stock | USD 1.74 0.24 12.12% |
Adamis Pharma fundamentals help investors to digest information that contributes to Adamis Pharma's financial success or failures. It also enables traders to predict the movement of Adamis Stock. The fundamental analysis module provides a way to measure Adamis Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Adamis Pharma stock.
Adamis |
Adamis Pharma Company Number Of Shares Shorted Analysis
Adamis Pharma's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Adamis Pharma Number Of Shares Shorted | 98.94 K |
Most of Adamis Pharma's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adamis Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Adamis Pharma has 98.94 K of outstending shares currently sold short by investors. This is 96.91% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The number of shares shorted for all United States stocks is 97.9% higher than that of the company.
Adamis Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adamis Pharma's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Adamis Pharma could also be used in its relative valuation, which is a method of valuing Adamis Pharma by comparing valuation metrics of similar companies.Adamis Pharma is currently under evaluation in number of shares shorted category among its peers.
Adamis Fundamentals
| Return On Equity | -7.85 | |||
| Return On Asset | -1.04 | |||
| Operating Margin | (3.74) % | |||
| Current Valuation | 7.28 M | |||
| Shares Outstanding | 9.36 M | |||
| Shares Owned By Insiders | 7.81 % | |||
| Shares Owned By Institutions | 16.59 % | |||
| Number Of Shares Shorted | 98.94 K | |||
| Price To Earning | (6.21) X | |||
| Price To Book | 8.62 X | |||
| Price To Sales | 17.64 X | |||
| Revenue | 4.76 M | |||
| Gross Profit | (1.43 M) | |||
| EBITDA | (24.27 M) | |||
| Net Income | (26.48 M) | |||
| Cash And Equivalents | 8.88 M | |||
| Cash Per Share | 0.06 X | |||
| Total Debt | 342.56 K | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 1.58 X | |||
| Book Value Per Share | (4.24) X | |||
| Cash Flow From Operations | (25.9 M) | |||
| Short Ratio | 0.02 X | |||
| Earnings Per Share | (10.14) X | |||
| Target Price | 0.42 | |||
| Number Of Employees | 11 | |||
| Beta | 1.28 | |||
| Market Capitalization | 7.25 M | |||
| Total Asset | 10.93 M | |||
| Retained Earnings | (304.56 M) | |||
| Working Capital | (2.12 M) | |||
| Current Asset | 4.15 M | |||
| Current Liabilities | 2.75 M | |||
| Z Score | -33.43 | |||
| Net Asset | 10.93 M |
About Adamis Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adamis Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adamis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adamis Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Adamis Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adamis Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adamis Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Adamis Stock
Moving against Adamis Stock
| 0.94 | SSNLF | Samsung Electronics | PairCorr |
| 0.94 | PTAIF | PT Astra International | PairCorr |
| 0.87 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.87 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.87 | HD | Home Depot Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Adamis Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adamis Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adamis Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adamis Pharma to buy it.
The correlation of Adamis Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adamis Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adamis Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adamis Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Adamis Stock
If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |